Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [Internet].

Kulasingam SL, Havrilesky L, Ghebre R, Myers ER.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May.

2.

Screening for Cervical Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Vesco KK, Whitlock EP, Eder M, Lin J, Burda BU, Senger CA, Holmes RS, Fu R, Zuber S.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May.

4.

Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study.

Del Mistro A, Frayle-Salamanca H, Trevisan R, Matteucci M, Pinarello A, Zambenedetti P, Buoso R, Fantin GP, Zorzi M, Minucci D.

Gynecol Oncol. 2010 Apr;117(1):77-81. doi: 10.1016/j.ygyno.2010.01.003. Epub 2010 Feb 8.

PMID:
20116836
5.

How many cervical cancers are prevented by treatment of screen-detected disease in young women?

Sasieni P, Castanon A, Parkin DM.

Int J Cancer. 2009 Jan 15;124(2):461-4. doi: 10.1002/ijc.23922.

6.

The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings.

Cárdenas-Turanzas M, Nogueras-Gonzalez GM, Scheurer ME, Adler-Storthz K, Benedet JL, Beck JR, Follen M, Cantor SB.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2865-71. doi: 10.1158/1055-9965.EPI-08-0137.

7.

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.

Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E.

BMJ. 2008 Sep 18;337:a1284. doi: 10.1136/bmj.a1284. Review.

8.

Five-year routine cervical cancer screening rates and intervals in a US health plan.

Schabert VF, Ye X, Insinga RP, Singhal PK, Riedel AA.

Curr Med Res Opin. 2008 Sep;24(9):2429-35. doi: 10.1185/03007990802281671 . Epub 2008 Jul 24.

PMID:
18662493
9.

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC.

Lancet Oncol. 2008 May;9(5):425-34. doi: 10.1016/S1470-2045(08)70103-7. Epub 2008 Apr 11.

PMID:
18407790
10.

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.

Kulasingam SL, Benard S, Barnabas RV, Largeron N, Myers ER.

Cost Eff Resour Alloc. 2008 Feb 15;6:4. doi: 10.1186/1478-7547-6-4.

11.

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J.

Obstet Gynecol. 2008 Jan;111(1):167-77. doi: 10.1097/01.AOG.0000296488.85807.b3. Review.

PMID:
18165406
12.

Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists.

Cai B, Ronnett BM, Stoler M, Ferenczy A, Kurman RJ, Sadow D, Alvarez F, Pearson J, Sings HL, Barr E, Liaw KL.

Am J Surg Pathol. 2007 Dec;31(12):1854-60.

PMID:
18043039
13.

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL; Canadian Cervical Cancer Screening Trial Study Group.

N Engl J Med. 2007 Oct 18;357(16):1579-88.

14.

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.

Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference.

Am J Obstet Gynecol. 2007 Oct;197(4):346-55. Review.

PMID:
17904957
15.

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference.

Am J Obstet Gynecol. 2007 Oct;197(4):340-5. Review.

PMID:
17904956
16.

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.

Carreon JD, Sherman ME, Guillén D, Solomon D, Herrero R, Jerónimo J, Wacholder S, Rodríguez AC, Morales J, Hutchinson M, Burk RD, Schiffman M.

Int J Gynecol Pathol. 2007 Oct;26(4):441-6.

PMID:
17885496
17.

Management of cervical intraepithelial neoplasia 2 in adolescent and young women.

Fuchs K, Weitzen S, Wu L, Phipps MG, Boardman LA.

J Pediatr Adolesc Gynecol. 2007 Oct;20(5):269-74.

18.

Deaths: final data for 2004.

Miniño AM, Heron MP, Murphy SL, Kochanek KD; Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System.

Natl Vital Stat Rep. 2007 Aug 21;55(19):1-119.

19.

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial.

Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C, Ghiringhello B, Giorgi-Rossi P, Minucci D, Parisio F, Pojer A, Schiboni ML, Sintoni C, Zorzi M, Segnan N, Confortini M.

BMJ. 2007 Jul 7;335(7609):28. Epub 2007 May 21.

20.

Prevalence of HPV infection among females in the United States.

Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE.

JAMA. 2007 Feb 28;297(8):813-9.

PMID:
17327523

Supplemental Content

Support Center